Receptor, Angiotensin, Type 2
"Receptor, Angiotensin, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.
| Descriptor ID |
D044139
|
| MeSH Number(s) |
D12.776.543.750.695.047.687 D12.776.543.750.750.130.875
|
| Concept/Terms |
Receptor, Angiotensin, Type 2- Receptor, Angiotensin, Type 2
- Angiotensin II Type 2 Receptor
- Angiotensin Type 2 Receptor
- Angiotensin AT2 Receptor
- AT2 Receptor, Angiotensin
- Receptor, Angiotensin AT2
- Receptor, Angiotensin II Type 2
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Angiotensin, Type 2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Angiotensin [D12.776.543.750.695.047]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.695.047.687]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Angiotensin [D12.776.543.750.750.130]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.750.130.875]
Below are MeSH descriptors whose meaning is more specific than "Receptor, Angiotensin, Type 2".
This graph shows the total number of publications written about "Receptor, Angiotensin, Type 2" by people in this website by year, and whether "Receptor, Angiotensin, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 4 | 4 | 8 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor, Angiotensin, Type 2" by people in Profiles.
-
Exploring Koch's postulate for SARS-CoV-2-induced acute pancreatitis: is it all about the ACE? Br J Surg. 2021 08 19; 108(8):879-881.
-
AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells. IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug; 18(4):1230-1233.
-
Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. J Neuroinflammation. 2021 Jul 29; 18(1):167.
-
Variants in AGTR2 gene in Maya people with COVID-19. Gene. 2021 Aug 30; 795:145794.
-
Dysregulation of COVID-19 related gene expression in the COPD lung. Respir Res. 2021 May 29; 22(1):164.
-
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling. Hypertension. 2021 06; 77(6):1845-1856.
-
Coronavirus infection: An immunologists' perspective. Scand J Immunol. 2021 Jun; 93(6):e13043.
-
In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity. Vascul Pharmacol. 2021 06; 138:106856.
-
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond). 2021 01 29; 135(2):387-407.
-
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses. 2021 Feb; 147:110486.